Sri Lanka’s pharma industry with 1959-roots still producing only 15% of national requirement Locally manufactured drugs have only 5% market share in private pharma market Morison...
Hemas Holdings PLC (HHL) delivered resilient results in the first six months of the financial year 2023/24 to post a cumulative Group revenue of Rs. 59.0...
Hemas Chairman says he is sad to see her go, but respects her decision Board initiates headhunting to identify a successor By Sanath Nanayakkare Hemas Holdings...
UNICEF on Friday launched the Business Council, a strategic partnership between UNICEF and top business leaders and decision-makers to advance child rights and sustainable development in...
Hemas Holdings PLC delivered a commendable performance in the first nine months of the financial year 2023. Notwithstanding the volatile economic conditions, the Group posted a...